A first-in-man phase I trial of a new monoclonal antibody labelled with yttrium 90 for radioimmunotherapy of relapsed or refractory non resectable synovial-sarcomas
Centre Léon Bérard, Lyon, France;Laboratoires OncoTherapy Science, France, Lyon, France;Institute of Medical Science, University of Tokyo, Tokyo, Japan;4OncoTherapy Science, Kanagawa, Japan